The Brain Health Study: A Pragmatic, Patient-Centered Trial

Kaiser Permanente

Status: Active, not recruiting

Conditions: Alzheimer Disease; Dementia

Treatments: Other: Brain Health Assessment

Study type: Interventional

Funder types: Other

Identifiers

NCT05356702

1R01AG067427 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.

Full description

eRADAR stands for "electronic health record (EHR) Risk of Alzheimer's and Dementia Assessment Rule." It is a low-cost tool or algorithm that uses readily available EHR data elements to identify high-risk patients. We will conduct a pragmatic randomized controlled trial to assess the impact of implementing eRADAR as part of a supported outreach process on dementia detection rates. We will also explore the impact of eRADAR implementation on healthcare utilization and patient experience.

Enrollment: 3,417 patients

Sex: All

Ages: 65+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• No prior diagnosis of dementia (defined from EHR diagnosis codes) and not receiving medications for dementia
• Active patient at participating clinic
• Adequate data to calculate eRADAR score

Exclusion criteria

• Currently receiving hospice care

Trial design

Primary purpose: Screening

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

3,417 participants in 2 patient groups

Brain Health Intervention

Experimental group

Description:

* Calculate eRADAR scores using EHR data to identify eligible individuals * Invite eligible individuals for brain health assessment visit * Enter results of brain health assessment visit into EHR * Provide summary of results and recommended next steps to the Primary Care Physician and participant

Treatment:

Other: Brain Health Assessment

Usual care

No Intervention group

Description:

Individuals who meet eligibility criteria will receive usual care.